Turn Biotechnologies Licenses Revolutionary Technology to Unwind the Effects of Aging at a Cellular Level

Turn Biotechnologies, a Shanda VC portfolio company developing medicines for currently untreatable age-related conditions, announced that it has acquired the global rights for new technology that reprograms cells to undo many of the effects of aging.


Read more

You might also interested in